These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12575759)

  • 41. A new deletion of the 5 alpha-reductase type 2 gene in a Turkish family with 5 alpha-reductase deficiency.
    Boudon C; Lobaccaro JM; Lumbroso S; Ogur G; Ocal G; Belon C; Sultan C
    Clin Endocrinol (Oxf); 1995 Aug; 43(2):183-8. PubMed ID: 7554313
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disorders of sexual development.
    Zajac JD; Warne GL
    Baillieres Clin Endocrinol Metab; 1995 Jul; 9(3):555-79. PubMed ID: 7575332
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transient expression of the 5alpha-reductase type 2 isozyme in the rat brain in late fetal and early postnatal life.
    Poletti A; Negri-Cesi P; Rabuffetti M; Colciago A; Celotti F; Martini L
    Endocrinology; 1998 Apr; 139(4):2171-8. PubMed ID: 9529007
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 alpha-reductase deficiency.
    Imperato-McGinley J; Peterson RE; Gautier T; Cooper G; Danner R; Arthur A; Morris PL; Sweeney WJ; Shackleton C
    J Clin Endocrinol Metab; 1982 May; 54(5):931-41. PubMed ID: 6801078
    [No Abstract]   [Full Text] [Related]  

  • 45. Androgen resistance syndromes.
    Griffin JE; Leshin M; Wilson JD
    Am J Physiol; 1982 Aug; 243(2):E81-7. PubMed ID: 7051848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism.
    Andersson S; Berman DM; Jenkins EP; Russell DW
    Nature; 1991 Nov; 354(6349):159-61. PubMed ID: 1944596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 5alpha-reductases in human breast carcinoma: possible modulator of in situ androgenic actions.
    Suzuki T; Darnel AD; Akahira JI; Ariga N; Ogawa S; Kaneko C; Takeyama J; Moriya T; Sasano H
    J Clin Endocrinol Metab; 2001 May; 86(5):2250-7. PubMed ID: 11344235
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnosis of 5alpha-reductase 2 deficiency: a local experience.
    Chan AO; But BW; Lau GT; Lam AL; Ng KL; Lam YY; Lee CY; Shek CC
    Hong Kong Med J; 2009 Apr; 15(2):130-5. PubMed ID: 19342739
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dihydrotestosterone stimulates 5 alpha-reductase activity in pubic skin fibroblasts.
    Mowszowicz I; Melanitou E; Kirchhoffer MO; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1983 Feb; 56(2):320-5. PubMed ID: 6218182
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The syndromes of androgen resistance revisited.
    Pérez-Palacios G; Chávez B; Méndez JP; McGinley JI; Ulloa-Aguirre A
    J Steroid Biochem; 1987; 27(4-6):1101-8. PubMed ID: 3320547
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotype, hormonal profile and genotype of subjects with partial androgen insensitivity syndrome: report of a family with four adult males and one child with disorder of sexual differentiation.
    Kulshreshtha B; Philibert P; Eunice M; Audran F; Paris F; Khurana ML; Ammini AC; Charles S
    Andrologia; 2009 Aug; 41(4):257-63. PubMed ID: 19601939
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of 5α-reductase activity and isoenzymes in human abdominal adipose tissues.
    Fouad Mansour M; Pelletier M; Tchernof A
    J Steroid Biochem Mol Biol; 2016 Jul; 161():45-53. PubMed ID: 26855069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Isabel Forshall Lecture. Surgical management of the intersex patient: an overview in 2003.
    Nihoul-Fékété C
    J Pediatr Surg; 2004 Feb; 39(2):144-5. PubMed ID: 14966728
    [No Abstract]   [Full Text] [Related]  

  • 54. Androgen insensitivity syndrome.
    Mendoza N; Motos MA
    Gynecol Endocrinol; 2013 Jan; 29(1):1-5. PubMed ID: 22812659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Disorders linked to insufficient androgen action in male children.
    Sultan C; Paris F; Terouanne B; Balaguer P; Georget V; Poujol N; Jeandel C; Lumbroso S; Nicolas JC
    Hum Reprod Update; 2001; 7(3):314-22. PubMed ID: 11392378
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Normal bone density in male pseudohermaphroditism due to 5alpha- reductase 2 deficiency.
    Frade Costa EM; Prado Arnhold IJ; Inacio M; Mendonca BB
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(5):139-42. PubMed ID: 11781593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Partial androgen insensitivity syndrome with persistent müllerian remnants. A case report.
    Bermejo-Costa F; Lloreda-García JM; Donate-Legaz JM
    Endocrinol Nutr; 2015 Nov; 62(9):469-71. PubMed ID: 26242926
    [No Abstract]   [Full Text] [Related]  

  • 58. High dose androgen therapy in male pseudohermaphroditism due to 5 alpha-reductase deficiency and disorders of the androgen receptor.
    Price P; Wass JA; Griffin JE; Leshin M; Savage MO; Large DM; Bu'Lock DE; Anderson DC; Wilson JD; Besser GM
    J Clin Invest; 1984 Oct; 74(4):1496-508. PubMed ID: 6480833
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development.
    Ittiwut C; Pratuangdejkul J; Supornsilchai V; Muensri S; Hiranras Y; Sahakitrungruang T; Watcharasindhu S; Suphapeetiporn K; Shotelersuk V
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):19-26. PubMed ID: 27849622
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stable maintenance of 5alpha-reductase activity in long-term subcultures of fibroblasts derived from the foreskin.
    Nakae K; Tsuji M; Kuraoka T; Cho S; Cunha GR; Shima H
    Int J Urol; 2002 Jun; 9(6):347-53. PubMed ID: 12110100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.